The DOI matches its Crossref record; 19 of the 21 references it cites were found in a registry or an index, and 2 are not checked yet.
Effect of Propionibacteria Supplementation on Fecal Bifidobacteria and Segmental Colonic Transit Time in Healthy Human Subjects
Abstract
BACKGROUND: Some strains of Propionibacterium have bifidogenic properties and enhance gut motility in the animal. However, they are not part of the indigenous fecal flora. This study was designed to assess the digestive survival of ingested propionibacteria, their bifidogenic properties, and the resulting changes in colonic transit time in healthy humans. METHODS: Eighteen subjects were given 5 . 10(10) CFU propionibacteria/day during 2 weeks. Fecal concentrations of propionibacteria and bifidobacteria were counted before (day -8, day -1), during (day 7, day 14), and after (day 21, day 28) the supplementation. Colonic transit time was measured before and at the end of the 1st week of supplementation. RESULTS: Basal counts of propionibacteria were less than 5 log CFU/ml stools. They increased in 15 subjects to (mean+/-1 standard deviation) 5.63+/-0.71 and 6.37+/-0.89 on day 7 (P < 0.01) and day 14 (P < 0.01) and returned to basal levels on day 21. Basal counts of bifidobacteria (mean, 7.94+/-0.71) increased to 8.39+/-0.97 on day 7, 8.36+/-0.86 on day 14, and 8.70+/-0.95 on day 21 (P < 0.05 from mean basal count) and returned to pretreatment levels on day 28 (7.88+/-1.38). Mean counts of propionibacteria during supplementation and bifidobacteria levels on day 14 were significantly correlated (P = 0.01). Transit time did not change in the right colon (17.4+/-8.1 h versus 17.3+/-8.3 h) or in the rectosigmoid area(12.8+/-8.5 versus 13.3+/-0.2 h); left colon transit was significantly slowed (7.0+/-5.0 h versus 11.9+/-9.4 h; P < 0.05). CONCLUSIONS: Part of the ingested propionibacteria were able to survive the digestive transit. This supplementation was associated with changes in segmental colonic motility, yet the mechanisms involved in these changes remain unknown.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The definition of a responder was based on the recommendations for global assessment of symptom relief in IBS trials (19) , which is the only available recommendation for such kinds of assessment.”
In the citing paper
“This scale was adapted from the scale developed by Guyatt et al. (18) and used in IBS studies (19) .”
In the citing paper
“Subjectreported assessment is endorsed to be the more meaningful and accurate measure for GI symptoms as compared with physician-reported assessments (19) .”
Citations
Cites
Normal Indigenous Intestinal Flora
FINEGOLD, S. M., SUTTER, V. L., & MATHISEN, G. E. (1983) · Human Intestinal Microflora in Health and Disease · doi:10.1016/b978-0-12-341280-5.50007-0 · Cited by 616
Segmental colonic transit time
Arhan, P., Devroede, G., Jehannin, B., Lanza, M., Faverdin, C., Dornic, C., Persoz, B., Tétreault, L., Perey, B., & Pellerin, D. (1981) · Diseases of the Colon & Rectum · doi:10.1007/bf02605761 · Cited by 466
Bifidobacteria and their role in human health
Mitsuoka, T. (1990) · Journal of Industrial Microbiology · doi:10.1007/bf01575871 · Cited by 385
Human Colonic Microbiota: Ecology, Physiology and Metabolic Potential of Intestinal Bacteria
Macfarlane, G. T., & Macfarlane, S. (1997) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.1997.11720708 · Cited by 342
Colonic microflora: Nutrition and health
Cummings, J. H., & Macfarlane, G. T. (1997) · Nutrition · doi:10.1016/s0899-9007(97)00114-7 · Cited by 260
What is the meaning of colorectal transit time measurement?
Bouchoucha, M., Devroede, G., Arhan, P., Strom, B., Weber, J., Cugnenc, P.-H., Denis, P., & Barbier, J.-P. (1992) · Diseases of the Colon & Rectum · doi:10.1007/bf02050328 · Cited by 198
Fecal recovery in humans of viable Bifidobacterium sp ingested in fermented milk
Bouhnik, Y., Pochart, P., Marteau, P., Arlet, G., Goderel, I., & Rambaud, J. C. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)90172-u · Cited by 188
Kaneko, T., Mori, H., Iwata, M., & Meguro, S. (1994) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(94)76965-4 · Cited by 151
Pedrosa, M. C., Golner, B. B., Goldin, B., Barakat, S., Dallal, G., & Russell, R. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/61.2.353 · Cited by 136
Mori, H., Satō, Y., Taketomo, N., Kamiyama, T., Yoshiyama, Y., Meguro, S., Sato, H., & Kaneko, T. (1997) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(97)76138-1 · Cited by 96
Research works printed but not linked: 14
- Romond MB, Yazourh A, Romond C. Les bifidobacterium entre pré- et probiotiques. Bull Soc Fr Microbiol 1997;12:27–31.
- Ebihara K, Miyada T, Nakajima A. Comparison of propionic acid and sodium propionate infused to the coecum and stomach on hypocholesterolemic effect in rat fed a cholesterol-free, casein protein diet. Nutr Res 1993;13:1305–11.
- Trinidad PT, Wolever TMS, Thompson LU. Effect of acetate and propionate on calcium absorption from the rectum and distal colon of humans. Am J Clin Nutr 1996;63:754–8.
- Zoreky NA, Ayres JW, Sandine WE. Characterization of propionibacterial growth metabolites inhibitory for gram negative bacteria. Cult Dairy Prod J 1993;28:4–13.
- Vorobjeva LI, Khodjaev EY, Cherdinceva TA. The study of induced antimutagenesis of propionic acid bacteria. J Microbiol Meth 1996;24:249–58.
- Roland N, Bouglé D, Lebeurrier F, Arhan P, Maubois JL Propionibacterium freudenreichii stimulate the growth of Bifidobacterium bifidum in vitro and increase fecal bifidobacteria in healthy human volunteers. Lactic 97; 1997 Sep 10–12; Caen, France.
- Seki M, Igarashi M, Fukuda Y, Simamura S, Kawashima T, Ogasa K. The effect of Bifidobacterium cultured milk on the ‘regularity’ among aged group. Nutr Food 1978;4:379–87.
- Bartram H-P, Scheppach W, Gerlach S, Ruckdeschel G, Kelber E, Kasper H. Does yogurt enriched with Bifidobacterium longum affect colonic microbiology and fecal metabolites in healthy subjects? Am J Clin Nutr 1994;59: 428–32.
- Kleessen B, Sykura B, Zunft H-J, Blaut M. Effects of inulin and lactose on fecal microflora, microbial activity, and bowel habit in elderly constipated persons. Am J Clin Nutr 1997;65:1397–402.
- Cherbut C, Aube AC, Blottière HM, Galmiche JP. Effects of short-chain fatty acids on gastrointestinal motility. Scand J Gastroenterol 1997;32 Suppl 222:58–61.
- Marteau P, Pochart P, Bouhnik Y, Zidi S, Goderel I, Rambaud JC. Survie, dans l’intestin grle, de Lactobacillus acidophilus et Bifidobacterium sp, ingérés dans un lait fermenté. Gastroenterol Clin Biol 1992;16:25–8.
- Kullen MJ, Amann MM, O’Shaughnessy MJ, O’Sullivan DJ, Busta FF, Brady LJ. Differentiation of ingested and endogenous Bifidobacteria by DNA fingerprinting demonstrates the survival of an unmodified strain in the gastrointestinal tract of humans. J Nutr 1997;127:89–94.
- Guerin-Danan C, Chabanet C, Pedone C, Popot F, Vaissade P, Bouley C, et al. Milk fermented with yogurt cultures and Lactobacillus casei compared with yogurt and gelled milk: influence on intestinal microflora in healthy infants. Am J Clin Nutr 1998;67:111–7.
- Thompson WG, Dotevall G, Drossman DA, Heaton KW, Kruis W. Irritable bowel syndrome: guidelines for the diagnosis. Gastroenterol Int 1989;2:92–5.
Cited by
Fate, activity, and impact of ingested bacteria within the human gut microbiota
Derrien, M., & van Hylckama Vlieg, J. E. T. (2015) · Trends in Microbiology · doi:10.1016/j.tim.2015.03.002 · Cited by 605
Jan, G., Belzacq, A.-S., Haouzi, D., Rouault, A., Métivier, D., Kroemer, G., & Brenner, C. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400935 · Cited by 385
“freudenreichii are generally recognized as safe bacteria and have already been used as human probiotics, mainly due to their bifidogenic effect.(41) Future clinical and/or epidemiological studies will determine whether these probiotics will also reduce the incidence of colon cancer.”
BackgroundMarteau, P., Cuillerier, E., Meance, S., Gerhardt, M. F., Myara, A., Bouvier, M., Bouley, C., Tondu, F., Bommelaer, G., & Grimaud, J. C. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01188.x · Cited by 254
Falentin, H., Deutsch, S.-M., Jan, G., Loux, V., Thierry, A., Parayre, S., Maillard, M.-B., Dherbécourt, J., Cousin, F. J., Jardin, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011748 · Cited by 227
“freudenreichii, as the bifidogenic compound it produces, 1,4dihydroxy-2-naphthoic acid (DHNA) [11], [12], stimulates growth of bifidobacteria, which has been shown to be beneficial for human health [13], [14].”
BackgroundNew insights into physiology and metabolism of Propionibacterium freudenreichii
Thierry, A., Deutsch, S.-M., Falentin, H., Dalmasso, M., Cousin, F. J., & Jan, G. (2011) · International Journal of Food Microbiology · doi:10.1016/j.ijfoodmicro.2011.04.026 · Cited by 209
“The bi fi dogenic effect of selected strains of P. freudenreichii was observed in independent studies performed on human volunteers (Bouglé et al., 1999; Hojo et al., 2002; Satomi et al., 1999).”
Background
Metadata
- Authors
- D. Bouglé, N. R.
- Venue
- Scandinavian Journal of Gastroenterology
- Publisher
- Informa UK Limited
- Published
- 1999-01
- Volume
- 34
- Issue
- 2
- Pages
- 144-148
- ISSN
- 0036-5521 (ISSN-L)
- 1502-7708
- OpenAlex
- W2110146962
- Cited by
- 92
- References
- 19
- Citations by year
- 2024: 2 · 2023: 3 · 2021: 2 · 2020: 3 · 2019: 4 · 2018: 5 · 2017: 6 · 2016: 2 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 5
- FWCI
- 5.33
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Scandinavian Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Propionibacterium, Bifidobacterium, probiotic supplementation, colonic transit time, intestinal motility, fecal microbiota, healthy volunteers, rectosigmoid, left colon, dietary fat, dietary protein, dietary fiber to fat ratio, dietary fiber to protein ratio
- MeSH terms
- Adult, Bifidobacterium, Colon, Feces, Gastrointestinal Transit, Humans, Male, Propionibacterium, Dietary Supplements
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of Propionibacteria Supplementation on Fecal Bifidobacteria and Segmental Colonic Transit Time in Healthy Human Subjects. https://app.cochat.ai/papers/10.1080/00365529950172998
- The paper
- D. Bouglé, N. R. (1999). Effect of Propionibacteria Supplementation on Fecal Bifidobacteria and Segmental Colonic Transit Time in Healthy Human Subjects. Scandinavian Journal of Gastroenterology. https://doi.org/10.1080/00365529950172998
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.